Conducting Exploratory Trials in Scandinavia

Debating where to take your trial? While emergent research settings like India and Asia have captured much of the media spotlight in recent years, there are few places in the world better-suited for phase 1 and phase 2 clinical trials than Scandinavia. Populations in the Nordic region are ethnically homogeneous with a majority of caucasians. Both governments and populations generally display a positive attitude toward clinical research, and trial participants have high compliance rates. All citizens have free and equal access to healthcare, preventing sampling bias due to differences in social status. Health care facilities in the region all have access to state-of-the-art medical equipment, and the infrastructure is of the highest standards. In this audio conference, the speaker discusses these and other factors that make the Scandinavian countries a leading choice for exploratory trials.

Conducting Exploratory Trials in Scandinavia is presented by Dr. Claes Strom, Partner and COO, of aCROnordic and airs Thursday, Oct. 30, 2008. For more details please visit our site www.fxconferences.com

How to Write for a Global Audience

In today's world, technical documentation must be designed for multiple audiences - both the users who read the text in translation, and those for whom English is a second language. By using Controlled English and authoring with an eye to translation, companies can make the entire process of product globalization faster, cheaper and less prone to errors.

This audio conference provides some basic guidelines on how to write for a global audience, enabling attendees to reduce the cost and improve the quality of translations, improve training and customer support, and protect their companies from litigation under the "failure to warn" principle.

How to Write for a Global Audience was presented by John Smart, President, SMART Communications on 2006-05-18 and is now available for download at www.fxconferences.com

Best Practices for Medical Device Design

Medical device design should not be the result of happenstance. Device development by happenstance might or might not be successful. However, there do exist within the process opportunities for improvement.

This presentation highlights brief case studies concerning the development of several novel medical devices. It will also examine the practical realities faced by the developers, and discuss their respective approaches. The presentation also looks at key factors leading to failures and successes of device design.

Best Practices for Medical Device Design was presented and recorded on 2005-03-16 and is now available for download at www.fxconferences.com

Changing Your Approach for Success in Post-Market Research

There is a growing industry awareness of post-marketing research, thanks to the many pressures surrounding this phase of drug development. The demands of new regulatory guidelines, decreased pipelines, challenges to extend life cycle management, and increases in drug and healthcare costs, have propelled pharmaceutical and biotech personnel into the world of post-marketing research. These changes have, in turn, made it necessary to understand the differences between pre-marketing and post-marketing environments.

In this audio conference, the speaker provides a fresh perspective and useful tools to help attendees strategically plan and execute post-marketing research.

Changing Your Approach for Success in Post-Market Research is presented by Maria Harrison, Vice President, Late Phase Development, of PRA International and airs Thursday, Oct. 16, 2008. For more information or to registration, please visit our site www.fxconferences.com

Partnering with the New e-Patient for Recruitment Success

The Internet has changed the way people approach their own health care, creating a new breed of engaged, empowered consumer known as the ‘e-patient’. They are taking charge of finding information about their diagnoses and treatment options, and they aren’t shy about interacting online with other patients to exchange experiences and learn more. The most active searchers, according to a groundbreaking white paper by Dr. Tom Ferguson and the e-Patients Scholars Working Group, are acute (newly diagnosed) and chronic patients – arguably, the optimal candidates for clinical trial participation.

This conference profiles the new e-patient, offers strategies for getting his/her attention, and assesses the benefits and challenges of partnering with this population to optimize clinical trial participation.

Partnering with the New e-Patient for Recruitment Success is presented by Linda Wolf & Yuriy Zhuk, of BBK Healthcare, and airs December 16th, 2008. For more details or to register, please visit our site www.fxconferences.com